NYXH NASDAQ
Nyxoah S.A.
1W: -1.7%
1M: -6.5%
3M: -36.9%
YTD: -36.2%
1Y: -62.7%
3Y: -63.9%
5Y: -87.6%
$2.87
+0.00 (+0.00%)
Weekly Expected Move ±8.3%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$107.2M
52W Range2.72-8.588
Volume106,342
Avg Volume52,682
Beta1.58
Dividend—
Analyst Ratings
Company Info
CEOOlivier Taelman
Employees183
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-04-28
Websitenyxoah.com
Rue Edouard Belin 12
Mont-Saint-Guibert 1435
BE
Mont-Saint-Guibert 1435
BE
32 1 022 23 55
About Nyxoah S.A.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Latest News
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Earnings Scheduled For May 12, 2026
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 10 juin 2026
Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 10, 2026
Recent Insider Trades
No insider trades found